Witvliet; Maarten Hendrik
Patent Applications and Registrations
Patent applications and USPTO patent grants for Witvliet; Maarten Hendrik.The latest application filed is for "vaccine to protect a pig against actinobacillus pleuropneumoniae".
- Witvliet; Maarten Hendrik - Oostrum NL
- Witvliet; Maarten Hendrik - Boxmeer NL
| Patent | Date |
|---|---|
| Vaccine To Protect A Pig Against Actinobacillus Pleuropneumoniae App 20220233675 - Witvliet; Maarten Hendrik ; et al. | 2022-07-28 |
| Vaccines containing swine pathogens for associated non-mixed use Grant 11,311,614 - Witvliet , et al. April 26, 2 | 2022-04-26 |
| Combination vaccine for swine Grant 11,065,324 - Jansen , et al. July 20, 2 | 2021-07-20 |
| A Vaccine To Protect A Pig Against Actinobacillus Pleuropneumoniae App 20210077610 - Witvliet; Maarten Hendrik ; et al. | 2021-03-18 |
| Combination Vaccine For Swine App 20200085935 - Jansen; Theodorus ; et al. | 2020-03-19 |
| Process for ready-to-use PCV/M.Hyo combination vaccine Grant 10,568,954 - Witvliet , et al. Feb | 2020-02-25 |
| Vaccines Containing Swine Pathogens For Associated Non-mixed Use App 20200046825 - WITVLIET; Maarten Hendrik ; et al. | 2020-02-13 |
| A Combination Vaccine Against Pcv2 Virus And Mycoplasma Hyopneumoniae Infection App 20190105385 - Sno; Melanie ; et al. | 2019-04-11 |
| A Vaccine For Intradermal Application Against Pcv2 And Prrs Virus Infection App 20190099480 - Sno; Melanie ; et al. | 2019-04-04 |
| Vaccine against porcine circo virus type 2 Grant 10,130,698 - Fachinger , et al. November 20, 2 | 2018-11-20 |
| Vaccine against Lawsonia intracellularis and porcine circovirus 2 Grant 10,130,699 - Jacobs , et al. November 20, 2 | 2018-11-20 |
| Process for Ready-to-Use PCV2/M.HYO Combination Vaccine App 20170340723 - WITVLIET; Maarten Hendrik ; et al. | 2017-11-30 |
| Vaccine Against Porcine Circo Virus Type 2 App 20170157236 - Fachinger; Vicky ; et al. | 2017-06-08 |
| Vaccine Against Lawsonia Intracellularis And Porcine Circovirus 2 App 20160303218 - Jacobs; Antonius Arnoldus Christiaan ; et al. | 2016-10-20 |
| Vaccine Comprising Inactivated Cells Of Haemophilus Parasuis Bacteria Of Serotype 5 App 20140178435 - Witvliet; Maarten Hendrik ; et al. | 2014-06-26 |
| Vaccine Against Mycoplasma, Hyopneumoniae, Suitable For Administration In The Presence Of Maternally Derived Antibodies App 20130064852 - Witvliet; Maarten Hendrik | 2013-03-14 |
| Vaccine Comprising Inactivated Cells Of Haemophilus Parasuis Bacteria Of Serotype 5 App 20130039941 - Witvliet; Maarten Hendrik ; et al. | 2013-02-14 |
| Vaccine for Protection Against Haemophilus Parasuis Serotype 4 in Piglets App 20110014237 - Segers; Ruud Philip Antoon Maria ; et al. | 2011-01-20 |
| Use of Clostridium perfringens type C bacterium for the manufacture of a vaccine App 20100062025 - Witvliet; Maarten Hendrik ; et al. | 2010-03-11 |
| Salmonella vaccine Grant 7,045,122 - Nuijten , et al. May 16, 2 | 2006-05-16 |
| Salmonella vaccine App 20040052802 - Nuijten, Petrus Johannes Maria ; et al. | 2004-03-18 |
| Salmonella vaccine App 20010021386 - Nuijten, Petrus Johannes Maria ; et al. | 2001-09-13 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 